O'Shea Genevieve, Teuteberg Jeffrey J, Severyn Donald A
University of Pittsburgh, Pittsburgh, PA, USA.
Prog Transplant. 2013 Mar;23(1):39-46. doi: 10.7182/pit2013494.
Ventricular assist devices provide therapeutic options for patients with severe heart failure who have exhausted available medical therapies. With restoration of organ perfusion with ventricular assist devices, the heart failure resolves and quality of life and functional status improve. The current generation of continuous-flow devices present novel challenges to the clinical assessment of patients by substantially reducing or nearly eliminating any palpable pulse. Patients therefore generally have inadequate arterial pulsatility for most noninvasive monitoring devices such as pulse oximeters or automated blood pressure cuffs to work accurately. This article describes the function of continuous-flow devices and how this function affects common monitoring options, as well as how to clinically assess recipients of continuous-flow devices to promptly identify those whose condition may be deteriorating or who may be receiving inadequate perfusion.
心室辅助装置为那些用尽了现有药物治疗手段的严重心力衰竭患者提供了治疗选择。随着心室辅助装置恢复器官灌注,心力衰竭得以缓解,生活质量和功能状态得到改善。当前一代的连续流装置给患者的临床评估带来了新挑战,因为它们大幅减少或几乎消除了任何可触及的脉搏。因此,对于大多数非侵入性监测设备,如脉搏血氧仪或自动血压袖带,患者通常没有足够的动脉搏动性来准确工作。本文描述了连续流装置的功能以及该功能如何影响常见的监测选项,还介绍了如何对连续流装置的接受者进行临床评估,以便及时识别那些病情可能恶化或灌注不足的患者。